ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Leap Therapeutics Inc

Leap Therapeutics Inc (LPTX)

0.5067
-0.031
( -5.77% )
更新日時: 05:05:32

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.5067
買値
0.5067
売値
0.5159
出来高
1,187,107
0.48 日の範囲 0.535
0.48 52 週間の範囲 4.79
時価総額
前日終値
0.5377
始値
0.535
最終取引時間
05:05:33
財務取引量
US$ 596,619
VWAP
0.502582
平均取引量 (3 か月)
749,404
発行済株式数
38,317,897
配当利回り
-
PER
-0.24
1 株当たり利益 (EPS)
-2.12
歳入
-
純利益
-81.41M

Leap Therapeutics Inc について

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhib... Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Leap Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker LPTX. The last closing price for Leap Therapeutics was US$0.54. Over the last year, Leap Therapeutics shares have traded in a share price range of US$ 0.48 to US$ 4.79.

Leap Therapeutics currently has 38,317,897 shares in issue. The market capitalisation of Leap Therapeutics is US$20.60 million. Leap Therapeutics has a price to earnings ratio (PE ratio) of -0.24.

LPTX 最新ニュース

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study PR Newswire CAMBRIDGE, Mass., Jan. 28, 2025 35% objective response rate (ORR...

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE, Mass., Jan. 6, 2025 CAMBRIDGE, Mass., Jan. 6, 2025 /PRNewswire/ -- Leap Therapeutics...

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference PR Newswire CAMBRIDGE, Mass., Nov. 26, 2024 CAMBRIDGE, Mass., Nov. 26, 2024 /PRNewswire/ -- Leap Therapeutics...

Leap Therapeutics Reports Third Quarter 2024 Financial Results

Leap Therapeutics Reports Third Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass., Nov. 13, 2024 CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.1533-23.22727272730.660.660.4815968460.54926235CS
4-2.9633-85.39769452453.473.50.4816117991.08759398CS
12-2.8333-84.82934131743.343.60970.487494041.70300641CS
26-1.4043-73.48508634221.9114.790.484518492.1192163CS
52-2.8733-85.00887573963.384.790.483403342.34259595CS
156-19.5933-97.479104477620.125.70.485274777.50960573CS
260-18.6933-97.360937519.241.70.4891747418.91552463CS

LPTX - Frequently Asked Questions (FAQ)

What is the current Leap Therapeutics share price?
The current share price of Leap Therapeutics is US$ 0.5067
How many Leap Therapeutics shares are in issue?
Leap Therapeutics has 38,317,897 shares in issue
What is the market cap of Leap Therapeutics?
The market capitalisation of Leap Therapeutics is USD 20.6M
What is the 1 year trading range for Leap Therapeutics share price?
Leap Therapeutics has traded in the range of US$ 0.48 to US$ 4.79 during the past year
What is the PE ratio of Leap Therapeutics?
The price to earnings ratio of Leap Therapeutics is -0.24
What is the reporting currency for Leap Therapeutics?
Leap Therapeutics reports financial results in USD
What is the latest annual profit for Leap Therapeutics?
The latest annual profit of Leap Therapeutics is USD -81.41M
What is the registered address of Leap Therapeutics?
The registered address for Leap Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Leap Therapeutics website address?
The website address for Leap Therapeutics is www.leaptx.com
Which industry sector does Leap Therapeutics operate in?
Leap Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
RFACURF Acquisition Corporation
US$ 10.12
(96.12%)
12.16k
RFACRF Acquisition Corporation
US$ 10.6299
(76.87%)
988.86k
RNAZTransCode Therapeutics Inc
US$ 9.41
(52.76%)
16.8M
ACBAurora Cannabis Inc
US$ 5.3696
(45.91%)
65.78M
CPIXCumberland Pharmaceutical Inc
US$ 5.3995
(43.60%)
56.66M
VLCNVolcon Inc
US$ 1.8503
(-42.18%)
3.49M
CSAICloudastructure Inc
US$ 8.40
(-35.29%)
207.96k
TCBPTC BioPharm Holdings PLC
US$ 0.2465
(-31.53%)
1.8M
CAPTCaptiVision Inc
US$ 0.72
(-31.43%)
7.91M
UPCUniverse Pharmaceuticals Inc
US$ 0.1863
(-30.97%)
30.41M
CYNCYNGN Inc
US$ 0.085726
(20.74%)
428.88M
RIMEAlgorhythm Holdings Inc
US$ 0.0209
(-14.34%)
216.94M
NVDANVIDIA Corporation
US$ 123.955
(4.47%)
204.63M
ASSTAsset Entities Inc
US$ 0.7698
(40.14%)
165.52M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.052901
(20.78%)
126.31M

LPTX Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock